Physician profile
Kenneth G Combs
NPI 1619971942
$564.79
in general payments reported to CMS, 2019-2025
11 companies · $154 in 2025
The $154 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.45 · 2020: $17.12 · 2021: $64.36 · 2022: $71.10 · 2023: $165 · 2024: $76.64 · 2025: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $395.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $394.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $283.06 | 2022-2025 | Shingrix, Arexvy, Bexsero |
| Abbvie INC. | $72.12 | 2021-2024 | Vraylar |
| Pfizer INC. | $41.72 | 2025 | |
| Inspire Medical Systems, INC. | $38.65 | 2023-2025 | Inspire |
| Janssen Pharmaceuticals, INC | $26.87 | 2021-2022 | |
| Biogen, INC. | $24.91 | 2021 | |
| Abbott Laboratories | $17.45 | 2019 | |
| Sumitomo Pharma America, INC. | $17.37 | 2025 | Gemtesa |
| Allergan, INC. | $17.12 | 2020 | |
| Merck Sharp & Dohme LLC | $13.07 | 2021 | |
| Endogastric Solutions, INC | $12.45 | 2024 | Esophyx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Combs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.